Suppr超能文献

膀胱内灌注黏菌素治疗多重耐药鲍曼不动杆菌尿路感染:一例报告

Intravesical colistin irrigation to treat multidrug-resistant Acinetobacter baumannii urinary tract infection: a case report.

作者信息

Volkow-Fernández Patricia, Rodríguez Cecilia Franco, Cornejo-Juárez Patricia

机构信息

Department of Infectious Diseases, Instituto Nacional de Cancerología, Avenida San Fernando No, 22, Colonia Sección XVI, Tlalpan, 14080, México, DF, Mexico.

出版信息

J Med Case Rep. 2012 Dec 28;6:426. doi: 10.1186/1752-1947-6-426.

Abstract

INTRODUCTION

Acinetobacter baumannii is a Gram-negative bacteria and a significant nosocomial pathogen in hospitals. Multidrug-resistant A. baumannii have emerged as a cause of nosocomial infections in critically ill patients. This microorganism has the ability to produce biofilms on different surfaces, which could explain their ability to persist in clinical environments and their role in device-related infections.

CASE PRESENTATION

We present the case of a 33-year-old Hispanic man with local invasive retroperitoneal leiomyosarcoma and right kidney exclusion along with femoral venous thrombosis, who was admitted for tumor resection. He had been receiving multiple nephrotoxic antibiotics for a long time (including tigecycline and colistimethate sodium) and had a persistent urinary infection related to multidrug-resistant A. baumannii (with susceptibility to colistimethate). Colistimethate was administered through a three-lumen urinary device for continuous urinary irrigation over seven days. Our patient did not refer to any adverse effects. A urine culture control taken at the end of the irrigation and another taken 10 days later were negative.

CONCLUSION

Colistimethate sodium and other antimicrobials infused by urinary irrigation can be a good option in patients in whom parenteral administration could be toxic.

摘要

引言

鲍曼不动杆菌是一种革兰氏阴性菌,是医院中重要的医院感染病原体。多重耐药鲍曼不动杆菌已成为重症患者医院感染的一个病因。这种微生物能够在不同表面形成生物膜,这可以解释它们在临床环境中持续存在的能力以及它们在与器械相关感染中的作用。

病例介绍

我们报告一例33岁西班牙裔男性病例,该患者患有局部侵袭性腹膜后平滑肌肉瘤并右肾切除,同时伴有股静脉血栓形成,因肿瘤切除入院。他长期接受多种肾毒性抗生素治疗(包括替加环素和多粘菌素甲磺酸钠),并患有与多重耐药鲍曼不动杆菌相关的持续性泌尿系统感染(对多粘菌素甲磺酸钠敏感)。多粘菌素甲磺酸钠通过三腔导尿管进行持续膀胱冲洗给药,持续7天。我们的患者未提及任何不良反应。冲洗结束时进行的尿培养及10天后再次进行的尿培养均为阴性。

结论

对于肠外给药可能有毒性的患者,膀胱冲洗注入多粘菌素甲磺酸钠及其他抗菌药物可能是一个不错的选择。

相似文献

5
Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
Pediatr Infect Dis J. 2009 Feb;28(2):123-7. doi: 10.1097/INF.0b013e31818a5dbd.
6
A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
Infect Chemother. 2016 Sep;48(3):190-198. doi: 10.3947/ic.2016.48.3.190. Epub 2016 Sep 9.
10
Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients.
Pediatr Int. 2010 Jun;52(3):410-4. doi: 10.1111/j.1442-200X.2009.03015.x. Epub 2009 Dec 2.

本文引用的文献

1
Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters.
FEMS Immunol Med Microbiol. 2011 Aug;62(3):328-38. doi: 10.1111/j.1574-695X.2011.00818.x. Epub 2011 Jun 28.
4
Global challenge of multidrug-resistant Acinetobacter baumannii.
Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84. doi: 10.1128/AAC.01464-06. Epub 2007 Jul 23.
6
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.
Lancet Infect Dis. 2006 Sep;6(9):589-601. doi: 10.1016/S1473-3099(06)70580-1.
7
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
Int J Antimicrob Agents. 2005 Jan;25(1):11-25. doi: 10.1016/j.ijantimicag.2004.10.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验